Ann Kristin Kvam

  • MD, PhD
 

Publications 2016

Barratt-Due A, Fløisand Y, Orrem HL, Kvam AK, Holme PA, Bergseth G, Tjønnfjord GE, Mollnes TE (2016)
Complement activation is a crucial pathogenic factor in catastrophic antiphospholipid syndrome
Rheumatology (Oxford), 55 (7), 1337-9
DOI 10.1093/rheumatology/kew040, PubMed 27105662

Publications 2015

Kvam AK, Waage A (2015)
Health-related quality of life in patients with multiple myeloma--does it matter?
Haematologica, 100 (6), 704-5
DOI 10.3324/haematol.2015.127860, PubMed 26034111

Publications 2013

Enden T, Wik HS, Kvam AK, Haig Y, Kløw NE, Sandset PM (2013)
Health-related quality of life after catheter-directed thrombolysis for deep vein thrombosis: secondary outcomes of the randomised, non-blinded, parallel-group CaVenT study
BMJ Open, 3 (8), e002984
DOI 10.1136/bmjopen-2013-002984, PubMed 23988361

Mellqvist UH, Gimsing P, Hjertner O, Lenhoff S, Laane E, Remes K, Steingrimsdottir H, Abildgaard N, Ahlberg L, Blimark C, Dahl IM, Forsberg K, Gedde-Dahl T, Gregersen H, Gruber A, Guldbrandsen N, Haukås E, Carlson K, Kvam AK, Nahi H, Lindås R, Andersen NF, Turesson I, Waage A, Westin J et al. (2013)
Bortezomib consolidation after autologous stem cell transplantation in multiple myeloma: a Nordic Myeloma Study Group randomized phase 3 trial
Blood, 121 (23), 4647-54
DOI 10.1182/blood-2012-11-464503, PubMed 23616624

Publications 2011

Kvam AK, Fayers PM, Wisloff F (2011)
Responsiveness and minimal important score differences in quality-of-life questionnaires: a comparison of the EORTC QLQ-C30 cancer-specific questionnaire to the generic utility questionnaires EQ-5D and 15D in patients with multiple myeloma
Eur J Haematol, 87 (4), 330-7
DOI 10.1111/j.1600-0609.2011.01665.x, PubMed 21668504

Publications 2010

Kvam AK, Wisløff F, Fayers PM (2010)
Minimal important differences and response shift in health-related quality of life; a longitudinal study in patients with multiple myeloma
Health Qual Life Outcomes, 8, 79
DOI 10.1186/1477-7525-8-79, PubMed 20678240

Publications 2009

Kvam AK, Fayers P, Hjermstad M, Gulbrandsen N, Wisloff F (2009)
Health-related quality of life assessment in randomised controlled trials in multiple myeloma: a critical review of methodology and impact on treatment recommendations
Eur J Haematol, 83 (4), 279-89
DOI 10.1111/j.1600-0609.2009.01303.x, PubMed 19558508

Kvam AK, Fayers P, Wisloff F (2009)
What changes in health-related quality of life matter to multiple myeloma patients? A prospective study
Eur J Haematol, 84 (4), 345-53
DOI 10.1111/j.1600-0609.2009.01404.x, PubMed 20041946

Publications 2006

Wisløff F, Kvam AK, Hjorth M, Lenhoff S (2006)
Serum calcium is an independent predictor of quality of life in multiple myeloma
Eur J Haematol, 78 (1), 29-34
DOI 10.1111/j.0902-4441.2006.t01-1-EJH2887.x, PubMed 17038019

Page visits: 307